Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Remember last time we had a nationwide Adderall shortage it was deliberately caused by Shire to force people onto Vyvanse.

Prior to Vyvanse Shire has signed a generic supplier agreement with TEVA so generic adderall was just the brand drug stamped differently. When they had Vyvanse ready they cancelled the agreement on short notice. That sent TEVA scrambling to stand up a production line.

Standing up a C2 line is a pain because of the DEA approvals and quotas. The quotas also prevent any of the other generic makers from ramping up their own production. The quota setting process is retrospective and by design it can't respond quickly to market changes like this.

So keep an eye out on who has a new patented medication for ADHD coming out and follow the money trail. The big drug companies love to turn a crisis into an opportunity and it wouldn't be surprised if they lobbied to include non-opioids in the settlement to give them cover for this sort of manipulation.



>Standing up a C2 line is a pain because of the DEA approvals and quotas

Why the hell do we have a quota on medication?


This feels like by far the most plausible explanation I’ve read today.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: